RET10Retatrutide 10 mg
Triple receptor agonist · GLP-1 / GIP / Glucagon · next-gen GLP
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2/3 trials show superior weight reduction versus dual agonists. 10 mg research vial.
For research use only. Not for human consumption.
Pricingchoose unit at checkout
Vial
Single vial
€49.90
Kit
Multi-vial pack
€247.50
For laboratory research use only. Not for human or veterinary consumption.
COA / lab tests
View all →- Retatrutide 10 mg — ERP batchJanoshik
Order
Unit
Quantity (vials)
Subtotal€49.90
Choose vial or kit above. For laboratory research use only.
